IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORUCCI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.369
EU - Europa 12.578
AS - Asia 11.726
SA - Sud America 2.288
Continente sconosciuto - Info sul continente non disponibili 927
AF - Africa 330
OC - Oceania 17
Totale 49.235
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.433
SG - Singapore 5.821
IE - Irlanda 2.057
UA - Ucraina 2.045
RU - Federazione Russa 1.794
BR - Brasile 1.753
IT - Italia 1.751
CN - Cina 1.520
SE - Svezia 1.483
HK - Hong Kong 1.294
VN - Vietnam 1.084
DE - Germania 781
FR - Francia 781
FI - Finlandia 659
GB - Regno Unito 479
CA - Canada 422
KR - Corea 368
IN - India 264
TR - Turchia 245
BD - Bangladesh 243
AR - Argentina 153
IQ - Iraq 136
MX - Messico 135
PL - Polonia 118
AT - Austria 100
CO - Colombia 98
ZA - Sudafrica 98
CH - Svizzera 92
NL - Olanda 89
PK - Pakistan 89
EC - Ecuador 86
ID - Indonesia 82
VE - Venezuela 81
ES - Italia 79
JP - Giappone 78
UZ - Uzbekistan 73
SA - Arabia Saudita 65
CR - Costa Rica 57
PH - Filippine 56
EE - Estonia 49
MA - Marocco 48
BE - Belgio 46
JM - Giamaica 44
SV - El Salvador 44
HN - Honduras 42
MY - Malesia 38
NI - Nicaragua 37
LB - Libano 35
PY - Paraguay 35
CZ - Repubblica Ceca 34
TT - Trinidad e Tobago 34
GT - Guatemala 33
GR - Grecia 31
IL - Israele 31
PR - Porto Rico 31
CL - Cile 30
KE - Kenya 30
AE - Emirati Arabi Uniti 27
RO - Romania 25
TN - Tunisia 25
EG - Egitto 23
CW - ???statistics.table.value.countryCode.CW??? 21
PE - Perù 21
KZ - Kazakistan 19
LT - Lituania 18
UY - Uruguay 18
ET - Etiopia 17
EU - Europa 15
JO - Giordania 15
NP - Nepal 15
AZ - Azerbaigian 14
OM - Oman 14
SC - Seychelles 14
TH - Thailandia 14
LY - Libia 13
PA - Panama 12
AU - Australia 11
BO - Bolivia 11
DZ - Algeria 11
GP - Guadalupe 10
KG - Kirghizistan 10
PS - Palestinian Territory 10
RS - Serbia 10
AL - Albania 9
BG - Bulgaria 9
TW - Taiwan 9
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
BB - Barbados 7
SN - Senegal 7
AM - Armenia 6
GE - Georgia 6
KW - Kuwait 6
BN - Brunei Darussalam 5
BS - Bahamas 5
DK - Danimarca 5
HR - Croazia 5
IR - Iran 5
NG - Nigeria 5
PT - Portogallo 5
Totale 48.237
Salva come PNG Salva come JPEG
Città #
Singapore 4.146
Chandler 2.286
Dublin 2.044
San Jose 1.940
Ashburn 1.852
Hong Kong 1.291
San Mateo 1.228
Jacksonville 847
Santa Clara 821
Boardman 744
Council Bluffs 716
Moscow 634
Dong Ket 622
Medford 548
Princeton 547
Altamura 518
Wilmington 501
Lauterbourg 495
Lawrence 383
Beijing 347
Andover 345
Ann Arbor 341
Perugia 332
Des Moines 320
Seoul 291
Los Angeles 262
New York 238
São Paulo 214
The Dalles 188
Saint Petersburg 165
Ho Chi Minh City 153
Helsinki 131
Izmir 120
Dallas 118
Munich 117
Piscataway 116
Hanoi 100
Norwalk 96
Falls Church 95
Brooklyn 87
Ottawa 85
Columbus 83
Phoenix 80
Toronto 76
Montreal 75
Orem 75
Shanghai 73
Warsaw 73
North Bergen 72
Tokyo 70
Chicago 64
Woodbridge 64
Baghdad 63
Houston 61
Rome 58
Frankfurt am Main 57
Rio de Janeiro 57
San Paolo di Civitate 57
Johannesburg 54
Chennai 51
Milan 51
Atlanta 50
London 50
Stockholm 47
Nuremberg 46
San José 46
Turku 46
Naples 45
Brussels 44
San Francisco 41
San Salvador 41
Mexico City 40
Buffalo 39
Manchester 39
Amsterdam 38
Vienna 38
Tashkent 37
Denver 36
Managua 35
Redwood City 35
Boston 34
Curitiba 34
Quito 34
Redmond 33
Dhaka 32
Ankara 30
Seattle 30
Bogotá 28
Lahore 28
Philadelphia 28
Brasília 27
Guayaquil 27
Poplar 27
Belo Horizonte 26
Charlotte 26
Auburn Hills 25
Den Haag 25
Florence 25
Kingston 25
Dearborn 24
Totale 29.099
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 198
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 168
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 160
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 159
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 154
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 153
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 151
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 150
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 150
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 148
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 147
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 146
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 146
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 144
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 144
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 142
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 142
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 142
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 141
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 139
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 138
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 137
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 137
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 137
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 136
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 134
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 133
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 133
Antiatherosclerotic effect of farnesoid X receptor. 132
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 132
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 129
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 129
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 128
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 127
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 127
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 127
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 125
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 125
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 124
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 124
.The vagal control of gallbladder motility is impaired in diabetics with autonomic neuropathy. 124
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 124
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 124
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 123
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 123
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 122
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 121
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 121
A magic bullet for mucosal protection...and aspirin is the trigger! 121
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 120
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 120
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 119
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 119
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 118
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 118
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 118
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 117
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 117
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 117
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 117
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 116
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 116
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 116
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 116
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 116
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 116
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 115
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 115
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 115
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 114
Nitric oxide inhibits hepatic stellate cell dependent tumor angiogenesis in primary and metastatic liver cancer 114
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 114
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 114
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 114
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 114
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 114
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 114
Bile Acid Signaling in Inflammatory Bowel Diseases 114
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 114
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 113
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 113
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 113
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 113
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 113
Primary brain abscess with Nocardia farcinica in an immunocompetent patient 113
D-2-antagonist levosulpiride inhibits afferent mediating perception of gastric distention in functional dyspepsia. 112
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 111
NO-NSAIDs are ICE/caspase1 inhibitors and protect from citokine-mediated acute liver failure induced by Concanavalin A in mice. 111
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 111
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 110
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 109
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 109
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 109
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 109
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 108
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 108
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 107
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 107
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 107
Alkaline esophageal reflux- A misnomer 107
Totale 12.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.348 0 0 0 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20256.875 69 695 224 227 902 284 247 602 1.423 456 1.066 680
2025/202614.534 1.059 898 860 1.698 1.799 1.247 2.610 769 1.709 1.233 407 245
2026/20274.974 359 465 869 3.281 0 0 0 0 0 0 0 0
Totale 49.235